Katrien Swerts

930 total citations
18 papers, 555 citations indexed

About

Katrien Swerts is a scholar working on Neurology, Cancer Research and Molecular Biology. According to data from OpenAlex, Katrien Swerts has authored 18 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 8 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Katrien Swerts's work include Neuroblastoma Research and Treatments (11 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Katrien Swerts is often cited by papers focused on Neuroblastoma Research and Treatments (11 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Katrien Swerts collaborates with scholars based in Belgium, Austria and United Kingdom. Katrien Swerts's co-authors include Jan Philippé, Geneviève Laureys, Yves Benoît, Catharina Dhooge, Susan A. Burchill, Barbara De Moerloose, Virginie Viprey, Maria Valeria Corrias, Klaus Beiske and Ruth Ladenstein and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Cancer.

In The Last Decade

Katrien Swerts

17 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrien Swerts Belgium 13 302 234 210 152 100 18 555
G M Marshall Australia 11 226 0.7× 70 0.3× 356 1.7× 262 1.7× 99 1.0× 20 664
Jessica Boklan United States 12 78 0.3× 41 0.2× 215 1.0× 118 0.8× 22 0.2× 30 467
Rosane Gomes de Paula Queiróz Brazil 13 37 0.1× 88 0.4× 278 1.3× 137 0.9× 17 0.2× 36 493
M. Eileen Dolan United States 8 21 0.1× 88 0.4× 332 1.6× 237 1.6× 30 0.3× 8 512
J Michon France 11 74 0.2× 18 0.1× 104 0.5× 56 0.4× 23 0.2× 37 330
R. C. Horns United States 6 11 0.0× 65 0.3× 159 0.8× 176 1.2× 99 1.0× 11 411
E. Pietrzak United States 6 14 0.0× 85 0.4× 119 0.6× 193 1.3× 126 1.3× 8 466
Winfried Alsdorf Germany 11 20 0.1× 32 0.1× 109 0.5× 98 0.6× 19 0.2× 37 298
K Sampi Japan 11 30 0.1× 22 0.1× 199 0.9× 137 0.9× 55 0.6× 55 476
Luciana Batista France 7 29 0.1× 306 1.3× 321 1.5× 127 0.8× 14 0.1× 10 620

Countries citing papers authored by Katrien Swerts

Since Specialization
Citations

This map shows the geographic impact of Katrien Swerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrien Swerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrien Swerts more than expected).

Fields of papers citing papers by Katrien Swerts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrien Swerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrien Swerts. The network helps show where Katrien Swerts may publish in the future.

Co-authorship network of co-authors of Katrien Swerts

This figure shows the co-authorship network connecting the top 25 collaborators of Katrien Swerts. A scholar is included among the top collaborators of Katrien Swerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrien Swerts. Katrien Swerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Viprey, Virginie, Walter M. Gregory, Maria Valeria Corrias, et al.. (2014). Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: A European HR-NBL1/SIOPEN Study. Journal of Clinical Oncology. 32(10). 1074–1083. 91 indexed citations
2.
Lammens, Tim, Katrien Swerts, Lara Derycke, et al.. (2012). N-Cadherin in Neuroblastoma Disease: Expression and Clinical Significance. PLoS ONE. 7(2). e31206–e31206. 37 indexed citations
3.
Vandewoestyne, Mado, Candy Kumps, Katrien Swerts, et al.. (2011). Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization. International Journal of Cancer. 130(5). 1098–1108. 6 indexed citations
4.
Menten, Björn, Katrien Swerts, Barbara Delle Chiaie, et al.. (2009). Array comparative genomic hybridization and flow cytometry analysis of spontaneous abortions and mors in utero samples. BMC Medical Genetics. 10(1). 89–89. 60 indexed citations
5.
Combaret, Valérie, Michael D. Hogarty, Wendy B. London, et al.. (2009). Influence of neuroblastoma stage on serum‐based detection of MYCN amplification. Pediatric Blood & Cancer. 53(3). 329–331. 29 indexed citations
6.
Cleemput, M. Van, Arne Heyerick, Claude Libert, et al.. (2009). Hop bitter acids efficiently block inflammation independent of GRα, PPARα, or PPARγ. Molecular Nutrition & Food Research. 53(9). 1143–1155. 30 indexed citations
7.
Viprey, Virginie, Maria Łastowska, Maria Valeria Corrias, et al.. (2008). Minimal disease monitoring by QRT–PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials. The Journal of Pathology. 216(2). 245–252. 34 indexed citations
8.
Viprey, Virginie, Maria Valeria Corrias, Bertil Kågedal, et al.. (2006). Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET. European Journal of Cancer. 43(2). 341–350. 47 indexed citations
9.
Swerts, Katrien, Nadine Van Roy, Yves Benoît, Geneviève Laureys, & Jan Philippé. (2006). DRAQ5: Improved flow cytometric DNA content analysis and minimal residual disease detection in childhood malignancies. Clinica Chimica Acta. 379(1-2). 154–157. 11 indexed citations
10.
Beiske, Klaus, Peter F. Ambros, Susan A. Burchill, Irene Y. Cheung, & Katrien Swerts. (2005). Detecting minimal residual disease in neuroblastoma patients-the present state of the art. Cancer Letters. 228(1-2). 229–240. 39 indexed citations
11.
Swerts, Katrien, Barbara De Moerloose, Catharina Dhooge, et al.. (2005). Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia. European Journal of Cancer. 42(3). 295–309. 60 indexed citations
12.
Swerts, Katrien, Barbara De Moerloose, Catharina Dhooge, et al.. (2005). Potential Application of ELAVL4 Real-Time Quantitative Reverse Transcription-PCR for Detection of Disseminated Neuroblastoma Cells. Clinical Chemistry. 52(3). 438–445. 25 indexed citations
13.
Swerts, Katrien, Peter F. Ambros, Chantal Brouzes, et al.. (2005). Standardization of the Immunocytochemical Detection of Neuroblastoma Cells in Bone Marrow. Journal of Histochemistry & Cytochemistry. 53(12). 1433–1440. 33 indexed citations
14.
Swerts, Katrien, Barbara De Moerloose, Catharina Dhooge, et al.. (2004). Detection of residual neuroblastoma cells in bone marrow: Comparison of flow cytometry with immunocytochemistry. Cytometry Part B Clinical Cytometry. 61B(1). 9–19. 23 indexed citations
15.
Swerts, Katrien, Barbara De Moerloose, Catharina Dhooge, et al.. (2004). Comparison of Two Functional Flow Cytometric Assays to Assess P-gp Activity in Acute Leukemia. Leukemia & lymphoma. 45(11). 2221–2228. 12 indexed citations
16.
Moerloose, Barbara De, Katrien Swerts, Yves Benoît, et al.. (2003). The Combined Analysis of P-Glycoprotein Expression and Activity Predicts Outcome in Childhood Acute Lymphoblastic Leukemia. Pediatric Hematology and Oncology. 20(5). 381–391. 5 indexed citations
17.
Moerloose, Barbara De, Katrien Swerts, Yves Benoît, et al.. (2003). The Combined Analysis of P-Glycoprotein Expression and Activity Predicts Outcome in Childhood Acute Lymphoblastic Leukemia. Pediatric Hematology and Oncology. 20(5). 381–391. 13 indexed citations
18.
Wiele, Christophe Van de, Barbara De Moerloose, Geneviève Laureys, et al.. (2001). Imaging with Technetium-99m sestamibi does not predict drug resistance or outcome in childhood neuroblastoma. Ghent University Academic Bibliography (Ghent University).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G M Marshall Breakdown of academic impact, for papers by Jessica Boklan Breakdown of academic impact, for papers by Rosane Gomes de Paula Queiróz Breakdown of academic impact, for papers by M. Eileen Dolan Breakdown of academic impact, for papers by J Michon Breakdown of academic impact, for papers by R. C. Horns Breakdown of academic impact, for papers by E. Pietrzak Breakdown of academic impact, for papers by Winfried Alsdorf Breakdown of academic impact, for papers by K Sampi Breakdown of academic impact, for papers by Luciana Batista
Rankless by CCL
2026